CORTEF (hydrocortisone) by Pfizer is clinical pharmacology glucocorticoids, naturally occurring and synthetic, are adrenocortical steroids that are readily absorbed from the gastrointestinal tract. Approved for dermatomyositis, temporal arteritis, polymyositis and 14 more indications.
Drug data last refreshed 12h ago · AI intelligence enriched 14h ago
CORTEF (hydrocortisone) is a naturally occurring glucocorticoid administered via injection for rapid anti-inflammatory and immunosuppressive effects. It treats a broad spectrum of autoimmune, inflammatory, and hematologic conditions including lupus, rheumatoid arthritis, asthma, ulcerative colitis, and leukemia/lymphoma. The drug works by modifying immune response and producing profound metabolic effects; the sodium succinate ester formulation enables immediate IV administration with demonstrable effects within one hour.
Pre-launch stage signals opportunity for new product teams ramping commercial infrastructure, though modest Part D spending ($683K) suggests limited current uptake or narrow market penetration.
CLINICAL PHARMACOLOGY Glucocorticoids, naturally occurring and synthetic, are adrenocortical steroids that are readily absorbed from the gastrointestinal tract. Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement…
Worked on CORTEF at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma
Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)
Intrathecal Cytarabine, Methotrexate, and Hydrocortisone for the Prevention of High-Grade Chimeric Antigen Receptor T-Cell-Associated Neurotoxicity Syndrome
HYDROcortisone Versus Placebo for Severe HospItal-acquired Pneumonia in Intensive Care Patients: the HYDRO-SHIP Study
Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moPfizer is hiring 10 roles related to this product
61 linked positions indicate active hiring across R&D, Commercial, Drug Safety, and Regulatory Affairs, suggesting a team ramping for product launch and post-market oversight. Roles span clinical research, sales, and regulatory execution, offering diverse career paths in a established-mechanism product with broad indication portfolio.
61 open roles linked to this drug